Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
BOSTON SCIENTIFIC CORP incurred senior notes of €850,000,000 with U.S. Bank Trust Company, National Association at 3.000% maturing due 2031.
- Instrument
- senior notes
- Principal
- €850,000,000
- Counterparty
- U.S. Bank Trust Company, National Association
- Rate
- 3.000%
- Maturity
- due 2031
- Event
- incurrence
Exact text from the filing
The Notes were issued pursuant to an indenture dated as of March 8, 2022 among AMS Europe, the Company and U.S. Bank Trust Company, National Association, as trustee (the “Indenture”). The Indenture contains covenants that restrict (i) the Company’s and AMS Europe’s ability, with certain exceptions, to merge or consolidate with another entity or transfer all or substantially all of its property and assets, and (ii) the Company’s and its Subsidiaries (as defined in the Indenture) ability, with certain exceptions, to incur liens.
View on SEC.gov
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
BOSTON SCIENTIFIC CORP incurred senior notes of €650,000,000 with U.S. Bank Trust Company, National Association at 3.250% maturing due 2034.
- Instrument
- senior notes
- Principal
- €650,000,000
- Counterparty
- U.S. Bank Trust Company, National Association
- Rate
- 3.250%
- Maturity
- due 2034
- Event
- incurrence
Exact text from the filing
The Notes were issued pursuant to an indenture dated as of March 8, 2022 among AMS Europe, the Company and U.S. Bank Trust Company, National Association, as trustee (the “Indenture”). The Indenture contains covenants that restrict (i) the Company’s and AMS Europe’s ability, with certain exceptions, to merge or consolidate with another entity or transfer all or substantially all of its property and assets, and (ii) the Company’s and its Subsidiaries (as defined in the Indenture) ability, with certain exceptions, to incur liens.
View on SEC.gov